Article
Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Biochemical and biophysical research communications - 26 Mar 2020
Yamanaka Satoshi, Sato Yusuke, Oikawa Daisuke, Goto Eiji, Fukai Shuya, Tokunaga Fuminori, Takahashi Hirotaka, Sawasaki Tatsuya
Abstract excerpt
The tumor suppressor CYLD negatively regulates polyubiquitination-dependent cellular signaling such as nuclear factor (NF)-κB signaling. In addition to CYLD, multiple deubiquitinating enzymes (DUBs) are also involved in the regulation of this signaling pathway, and distinct role of CYLD is yet to be clarified. Here, we identified a small chemical named Subquinocin that inhibited the DUB activity of recombinant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.